Mathieu Boulin

946 citations

57 papers · 676 indexed · h-index 17

Impact in

Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
Family Practice top 5%

Papers in ⓘ

Hepatology 22
- Hepatocellular Carcinoma Treatment and Prognosis 22
Oncology 15

Co-authors: Boris Guiu (22 shared papers)Jean–Pierre Cercueil (11 shared papers)Patrick Hillon (12 shared papers)Laurent Bedenne (8 shared papers)Serge Aho (11 shared papers)Bruno Chauffert (5 shared papers)Maëva Wendremaire (4 shared papers)Yves Cottin (9 shared papers)
Journals: Cancers (4 papers)International Journal of Environmental Research and Public Health (2 papers)CardioVascular and Interventional Radiology (2 papers)Journal of Vascular and Interventional Radiology (2 papers)BMJ Open (2 papers)
Partner nations: France United States New Zealand

In The Last Decade

Mathieu Boulin

51 papers receiving 665 citations

Peers

Countries citing papers authored by Mathieu Boulin

Since Specialization

Citations

This map shows the geographic impact of Mathieu Boulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Boulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Boulin more than expected).

Fields of papers citing papers by Mathieu Boulin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Boulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Boulin. The network helps show where Mathieu Boulin may publish in the future.

Co-authors

The 25 scholars most cited alongside Mathieu Boulin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mathieu Boulin Line = papers co-authored together Mathieu Boulin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma Anti-Cancer Drugs ·Mathieu Boulin, Séverine Guiu, Bruno Chauffert, Serge Aho, Jean–Pierre Cercueil, François Ghiringhelli, D. Krausé, Philippe Fagnoni, Patrick Hillon, Laurent Bedenne, Boris Guiu	2011	64
2	Idarubicin‐loaded beads for chemoembolisation of hepatocellular carcinoma: results of theIDASPHEREphase I trial Alimentary Pharmacology & Therapeutics ·Mathieu Boulin, Patrick Hillon, Jean–Pierre Cercueil, Franck Bonnetain, (unknown), Anne Minello, J L Jouve, Côme Lepage, Marc Bardou, Maëva Wendremaire, Pascal Guérard, Alban Denys, Aurélie Grandvuillemin, Bruno Chauffert, Laurent Bedenne, Boris Guiu	2014	49
3	Impact of COVID-19 lockdown on lifestyle adherence in stay-at-home patients with chronic coronary syndromes: Towards a time bomb International Journal of Cardiology ·A Cransac-Miet, Marianne Zeller, F. Chagué, Agnès Soudry Faure, F. Bichât, Nicolas Danchin, Mathieu Boulin, Yves Cottin	2020	37
4	Clinical and economic impact of pharmacist interventions in an ambulatory hematology–oncology department Journal of Oncology Pharmacy Practice ·Jonathan de Grégori, Pauline Pistre, Mérédith Boutet, L Porcher, Madeline Devaux, C Pernot, Marie Lorraine Chrétien, Cédric Rossi, Sylvain Manfrédi, S. Dalac, Pauline Gueneau, Mathieu Boulin	2020	37
5	Improved stability of lipiodol–drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin European Radiology ·Mathieu Boulin, Antonin Schmitt, E. Delhom, Jean–Pierre Cercueil, Maëva Wendremaire, D Imbs, Audrey Fohlen, Fabrizio Panaro, Astrid Herrero, Alban Denys, Boris Guiu	2015	34
6	Impact of Lockdown on Patients with Congestive Heart Failure During the Coronavirus Disease 2019 Pandemic ESC Heart Failure ·F. Chagué, Mathieu Boulin, Jean‐Christophe Eicher, F. Bichât, M Saint Jalmes, A Cransac-Miet, Agnès Soudry‐Faure, Nicolas Danchin, Yves Cottin, Marianne Zeller	2020	30
7	Idarubicin-Loaded ONCOZENE Drug-Eluting Embolic Agents for Chemoembolization of Hepatocellular Carcinoma: In Vitro Loading and Release and In Vivo Pharmacokinetics Journal of Vascular and Interventional Radiology ·Boris Guiu, Antonin Schmitt, Sven Reinhardt, Audrey Fohlen, Theresa Pohl, Maëva Wendremaire, Alban Denys, Jacques Blümmel, Mathieu Boulin	2014	30
8	Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II Trial Radiology ·Boris Guiu, P. Chevallier, Eric Assénat, Emilie Barbier, Philippe Merle, Antoine Bouvier, Jérôme Dumortier, Éric Nguyen-Khac, Jean Gugenheim, Agnès Rode, Frédéric Oberti, Pierre‐Jean Valette, Thierry Yzet, Olivier Chevallier, Jean‐Claude Barbare, Marianne Latournerie, Mathieu Boulin	2019	27
9	Serum Gamma-Glutamyl-Transferase Independently Predicts Outcome After Transarterial Chemoembolization of Hepatocellular Carcinoma: External Validation CardioVascular and Interventional Radiology ·Boris Guiu, Frédèric Deschamps, Mathieu Boulin, Valérie Boige, David Malka, Michel Ducreux, Patrick Hillon, Thierry de Baère	2011	24
10	Patterns of Surveillance Practices After Curative Surgery for Colorectal Cancer in a French Population Diseases of the Colon & Rectum ·Mathieu Boulin, Catherine Lejeune, Gwénaël Le Teuff, Christine Binquet, Anne‐Marie Bouvier, Laurent Bedenne, Claire Bonithon‐Kopp	2005	23
11	Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial Annals of Intensive Care ·Jean‐Pierre Quenot, Julie Helms, Abderrahmane Bourredjem, Auguste Dargent, Ferhat Meziani, Julio Badié, Gilles Blasco, Gaël Piton, Gilles Capellier, Chaouki Mezher, Jean-Michel Rebibou, Abdelouaïd Nadji, Thomas Crépin, Saber Davide Barbar, Camille Fleck, Amélie Cransac, Mathieu Boulin, Christine Binquet, Agnès Soudry‐Faure, Rémi Bruyère	2019	20
12	Adherence to immunomodulatory drugs in patients with multiple myeloma PLoS ONE ·Amélie Cransac, Serge Aho, Marie‐Lorraine Chrétien, Maurice Giroud, Denis Caillot, Mathieu Boulin	2019	19
13	Lipiodol Trans-arterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin: First Experience CardioVascular and Interventional Radiology ·Sylvain Favelier, Mathieu Boulin, Samia Hamza, Jean–Pierre Cercueil, Violaine Cherblanc, Côme Lepage, Patrick Hillon, Bruno Chauffert, D. Krausé, Boris Guiu	2012	19
14	Transarterial chemoembolization for hepatocellular carcinoma: An old method, now flavor of the day Diagnostic and Interventional Imaging ·Mathieu Boulin, E. Delhom, M.-A. Pierredon-Foulongne, Jean–Pierre Cercueil, Boris Guiu	2015	17
15	Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinoma Digestive and Liver Disease ·Mathieu Boulin, Héloïse Adam, Boris Guiu, Serge Aho, Jean–Pierre Cercueil, Cyrille Di Martino, Philippe Fagnoni, Anne Minello, Jean Louis Jouve, Patrick Hillon, Laurent Bedenne, Côme Lepage	2014	16
16	Preventing Unnecessary Costs of Drug-Induced Hypoglycemia in Older Adults with Type 2 Diabetes in the United States and Canada PLoS ONE ·Mathieu Boulin, Vakaramoko Diaby, Cara Tannenbaum	2016	16
17	Intra-arterial idarubicin_lipiodol without embolisation in hepatocellular carcinoma: The LIDA-B phase I trial Journal of Hepatology ·Boris Guiu, Jean–Louis Jouve, Antonin Schmitt, Anne Minello, Franck Bonnetain, Christophe Cassinotto, Lauranne Piron, Jean–Pierre Cercueil, Romaric Loffroy, Marianne Latournerie, Maëva Wendremaire, Côme Lepage, Mathieu Boulin	2018	16
18	Liver Chemoembolization of Hepatocellular Carcinoma using TANDEM ^® Microspheres Future Oncology ·Julien Delicque, Boris Guiu, Mathieu Boulin, Heidi Schwanz, Lauranne Piron, Christophe Cassinotto	2018	15
19	Efficacy, safety, and cost of pomalidomide in relapsed and refractory multiple myeloma European Journal Of Haematology ·Pauline Gueneau, Marie‐Lorraine Chrétien, A Cransac-Miet, Serge Aho, Ingrid Lafon, Camille Favennec, Julien Guy, Denis Caillot, Mathieu Boulin	2018	14
20	Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics Cancers ·Boris Guiu, Sébastien Colombat, Lauranne Piron, Margaux Hermida, Carole Allimant, Marie-Ange Pierredon-Foulongne, A. Belgour, Laure Escal, Christophe Cassinotto, Mathieu Boulin	2019	14

About Mathieu Boulin

Mathieu Boulin is a scholar working on Hepatology, Oncology, Pathology and Forensic Medicine, Epidemiology and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 676 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Cancer Mechanisms and Therapy (9 papers), Pharmaceutical Practices and Patient Outcomes (7 papers), Medication Adherence and Compliance (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Pharmaceutical studies and practices (5 papers), Renal cell carcinoma treatment (5 papers) and COVID-19 and Mental Health (5 papers). The work is most often cited by research in Hepatology (320 citations), Family Practice (41 citations), Geriatrics and Gerontology (51 citations), Pathology and Forensic Medicine (116 citations) and Hematology (70 citations). Mathieu Boulin has collaborated with scholars based in France, United States and New Zealand. Frequent co-authors include Boris Guiu, Jean–Pierre Cercueil, Patrick Hillon, Laurent Bedenne, Serge Aho, Bruno Chauffert, Maëva Wendremaire, Yves Cottin, Côme Lepage and Philippe Fagnoni. Their work appears in journals such as Cancers, International Journal of Environmental Research and Public Health, CardioVascular and Interventional Radiology, Journal of Vascular and Interventional Radiology and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact